These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 11128613

  • 1. Subcellular localization of alpha-synuclein in primary neuronal cultures: effect of missense mutations.
    McLean PJ, Ribich S, Hyman BT.
    J Neural Transm Suppl; 2000; (58):53-63. PubMed ID: 11128613
    [Abstract] [Full Text] [Related]

  • 2. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
    McLean PJ, Kawamata H, Hyman BT.
    Neuroscience; 2001; 104(3):901-12. PubMed ID: 11440819
    [Abstract] [Full Text] [Related]

  • 3. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.
    Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Sisk A, Masliah E.
    Lab Invest; 1998 Sep; 78(9):1169-77. PubMed ID: 9759660
    [Abstract] [Full Text] [Related]

  • 4. Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations.
    Kawamata H, McLean PJ, Sharma N, Hyman BT.
    J Neurochem; 2001 May; 77(3):929-34. PubMed ID: 11331421
    [Abstract] [Full Text] [Related]

  • 5. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT.
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
    [Abstract] [Full Text] [Related]

  • 6. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG, Goedert M.
    Ann N Y Acad Sci; 2000 Apr; 920():16-27. PubMed ID: 11193145
    [Abstract] [Full Text] [Related]

  • 7. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies.
    Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, Højrup P, Moos T, Otzen D, Gai WP, Blumbergs PC, Jensen PH.
    J Biol Chem; 2005 Feb 18; 280(7):5703-15. PubMed ID: 15590652
    [Abstract] [Full Text] [Related]

  • 8. Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein.
    Lauwers E, Debyser Z, Van Dorpe J, De Strooper B, Nuttin B, Baekelandt V.
    Brain Pathol; 2003 Jul 18; 13(3):364-72. PubMed ID: 12946025
    [Abstract] [Full Text] [Related]

  • 9. Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain.
    Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, Schindzielorz A, Okochi M, Leimer U, van Der Putten H, Probst A, Kremmer E, Kretzschmar HA, Haass C.
    J Neurosci; 2000 Sep 01; 20(17):6365-73. PubMed ID: 10964942
    [Abstract] [Full Text] [Related]

  • 10. Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations.
    McLean PJ, Kawamata H, Ribich S, Hyman BT.
    J Biol Chem; 2000 Mar 24; 275(12):8812-6. PubMed ID: 10722726
    [Abstract] [Full Text] [Related]

  • 11. Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification.
    Hishikawa N, Hashizume Y, Ujihira N, Okada Y, Yoshida M, Sobue G.
    Neuropathol Appl Neurobiol; 2003 Jun 24; 29(3):280-7. PubMed ID: 12787325
    [Abstract] [Full Text] [Related]

  • 12. Alpha-synuclein aggregation and neurodegenerative diseases.
    Ma QL, Chan P, Yoshii M, Uéda K.
    J Alzheimers Dis; 2003 Apr 24; 5(2):139-48. PubMed ID: 12719631
    [Abstract] [Full Text] [Related]

  • 13. Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.
    Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y.
    Brain Res; 2001 Jan 12; 888(2):287-296. PubMed ID: 11150486
    [Abstract] [Full Text] [Related]

  • 14. [Recent neuropathology of parkinsonian syndromes].
    Duyckaerts C, Verny M, Hauw JJ.
    Rev Neurol (Paris); 2003 May 12; 159(5 Pt 2):3S11-8. PubMed ID: 12773883
    [Abstract] [Full Text] [Related]

  • 15. Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS.
    Li J-, Henning Jensen P, Dahlström A.
    Neuroscience; 2002 May 12; 113(2):463-78. PubMed ID: 12127102
    [Abstract] [Full Text] [Related]

  • 16. Neuropathological spectrum of synucleinopathies.
    Jellinger KA.
    Mov Disord; 2003 Sep 12; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [Abstract] [Full Text] [Related]

  • 17. Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.
    Ancolio K, Alves da Costa C, Uéda K, Checler F.
    Neurosci Lett; 2000 May 12; 285(2):79-82. PubMed ID: 10793231
    [Abstract] [Full Text] [Related]

  • 18. Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease.
    Hegde ML, Jagannatha Rao KS.
    Arch Biochem Biophys; 2003 Oct 15; 418(2):169-78. PubMed ID: 14522588
    [Abstract] [Full Text] [Related]

  • 19. Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle.
    Uversky VN, Fink AL.
    FEBS Lett; 2002 Jul 03; 522(1-3):9-13. PubMed ID: 12095610
    [Abstract] [Full Text] [Related]

  • 20. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA.
    Acta Neuropathol; 2003 Sep 03; 106(3):191-201. PubMed ID: 12845452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.